Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Nov 7:24:118-120.
doi: 10.1016/j.phro.2022.11.004. eCollection 2022 Oct.

Achievements and challenges in normal tissue response modelling for proton therapy

Grete May Engeseth  1 , Camilla Stokkevåg  1   2 , Ludvig P Muren  3   4
Affiliations
Editorial

Achievements and challenges in normal tissue response modelling for proton therapy

Grete May Engeseth et al. Phys Imaging Radiat Oncol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Comment on

References

    1. Arscott W.T., Thompson R.F., Yin L., Burgdorf B., Kirk M., Ben-Josef E. Stereotactic body proton therapy for liver tumors: Dosimetric advantages and their radiobiological and clinical implications. Phys Imaging Radiat Oncol. 2018;8:17–22. - PMC - PubMed
    1. Yoshimura T., Nishioka K., Hashimoto T., Seki K., Kogame S., Tanaka S., et al. A treatment planning study of urethra-sparing intensity-modulated proton therapy for localized prostate cancer. Phys Imaging Radiat Oncol. 2021;20:23–29. - PMC - PubMed
    1. Oonsiri S., Kitpanit S., Kannarunimit D., Chakkabat C., Lertbutsayanukul C., Prayongrat A. Comparison of intensity modulated proton therapy beam configurations for treating thoracic esophageal cancer. Phys Imaging Radiat Oncol. 2022;22:51–56. - PMC - PubMed
    1. Langendijk J.A., Lambin P., De Ruysscher D., Widder J., Bos M., Verheij M. Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach. Radiother Oncol. 2013;107:267–273. - PubMed
    1. Widder J., van der Schaaf A., Lambin P., Marijnen C.A., Pignol J.P., Rasch C.R., et al. The quest for evidence for proton therapy: model-based approach and precision medicine. Int J Radiat Oncol Biol Phys. 2016;95:30–36. - PubMed

LinkOut - more resources